Benign epilepsy of childhood with occipital paroxysms (BECOP)
Last updated 10 Jun 2009, review date due 10 Mar 2012
BECOP can start at any age from 15 months to 17 years, but usually begins in middle childhood between seven and 11 years of age.
This epilepsy syndrome is often called ‘late-onset occipital epilepsy’ to separate it from ‘early-onset occipital epilepsy’ (also known as Panayiotopoulos syndrome).
About one third of children have a family history of epilepsy and some children have had seizures with feverish illnesses (febrile convulsions) before starting to have BECOP.
Most children with this condition have normal neurological and learning abilities. Brain scans are normal.
Diagnosis
In the electroencephalogram (EEG), which records the electrical activity in the brain, abnormalities are seen in the occipital region (the very back part of the brain).
As a result some children may have seizures as they go from a dark area into a brighter one, or from a well lit area into a dark one.
Symptoms
The seizures usually affect vision. Complete or partial visual loss occurs in about half the children who have this type of epilepsy. Some may experience a sensation of flashing lights, often multicoloured spots. Visual hallucinations (seeing things) are rare but occur in some children.
About half have jerking of one side of the body. Semi-purposeful movements and behaviour is rarer and generalised tonic clonic seizures may also occur.
Headaches are a very common feature of this epilepsy syndrome. These headaches may occur during or after the seizure.
Treatment
The seizures respond readily to anti-epileptic drugs such as sodium valproate (Epilim), or carbamazepine (Tegretol).
There is currently no information as to whether the newer anti-epileptic drugs may also be helpful in this syndrome (eg: lamotrigine (Lamictal), levetiracetam (Keppra) or topiramate (Topamax).
Prognosis (outlook)
The outlook is good for neurological development. There are educational problems only in rare cases. The seizures usually get better by puberty but in five to 10 out of 100 cases, they persist into adulthood.
Support organisations
Contact a Family,
209-211 City Road,
London, EC1V 1JN,
telephone 0808 808 3555,
http://www.cafamily.org.uk/
Epilepsy Action is indebted to Dr Richard Appleton, a Consultant Paediatric Neurologist who specialises in children’s epilepsy, and to Dr Rachel Kneen, Consultant Paediatric Neurologist and Dr Stewart Macleod, Specialist Registrar in paediatric neurology, at Alder Hey at Alder Hey Children’s Hospital, Liverpool, who have kindly prepared the information on this page.
Because this page is written by an epilepsy healthcare professional and not by Epilepsy Action, it falls outside the requirements of the Information Standard. This is why the Information Standard logo is not shown on this page.
- Information for...
- Information on...
- Fundraise
- Donate
- Membership
- Campaigns
- Take epilepsy action campaign
- Automatic substitution of anti-epileptic drugs
- National commissioning of paediatric epilepsy surgery
- National Epilepsy Week
- Save our Sapphires, protecting all epilepsy specialist nurse posts
- Women's campaigns
- Epilepsy in England: time for change
- 'Epilepsy Aware' scheme for GP practices and pharmacies
- Campaign Supporters' Group
- Surveys
- News
- Research
- Our services
- Forum
- About us
Epilepsy advice and information
- What is epilepsy?
- Caring for a baby or young child when you have epilepsy: a detailed guide
- Children
- Depression and epilepsy
- Developing epilepsy in later life
- Driving and epilepsy
- Education
- Entitlements and benefits for people with epilepsy
- Epilepsy and learning disabilities
- Epilepsy and Travel abroad
- Epilepsy information for prisons
- Epilepsy, osteoporosis and osteomalacia
- Epilepsy: diagnosis, treatment and healthcare in the UK
- Epileptic seizures explained
- Flu and epilepsy
- Identity jewellery
- Inheritance
- Me and my dad
- Memory
- Mobile phones and epilepsy
- Photosensitive epilepsy
- Safety advice for people with epilepsy
- Sports and leisure
- Stress and epilepsy
- Sudden unexpected death in epilepsy (SUDEP)
- Syndromes
- Aicardi syndrome
- Angelman syndrome
- Benign epilepsy of childhood with occipital paroxysms (BECOP)
- Benign myoclonic epilepsy in infancy
- Benign neonatal convulsions
- Benign partial epilepsy in infancy
- Benign rolandic epilepsy
- Childhood absence epilepsy (CAE)
- Early myoclonic encephalopathy
- Electrical status epilepticus during slow-wave sleep (ESESS)
- Epilepsy with myoclonic absences
- Eyelid myoclonia with absences (EMA)
- Gelastic Epilepsy
- Generalised epilepsy with febrile seizure plus (GEFS+)
- Juvenile myoclonic epilepsy (JME)
- Landau Kleffner Syndrome
- Lennox-Gastaut Syndrome
- Migrating partial epilepsy in infancy
- Myoclonic astatic epilepsy (Doose syndrome)
- Ohtahara Syndrome
- Panayiotopoulos syndrome
- Pyridoxine dependency
- Rasmussen syndrome
- Rett syndrome
- Ring chromosome 20 syndrome
- Severe myoclonic epilepsy in infancy (SMEI)
- Sturge-Weber syndrome
- Unverricht-Lundborg syndrome
- West syndrome (infantile spasms)
- The Disability Discrimination Act
- The Equality Act and epilepsy
- Vagus nerve stimulation therapy in epilepsy
- Work and epilepsy
- Women and epilepsy
- Young people and epilepsy
- Epilepsy Action and the Information Standard
- The Epilepsies: You, Epilepsy and the NICE Guideline
- Epilepsy Action Information Reviewers (EAIRs)
- Technical editing/writing and copyright
Epilepsy Helpline
- UK freephone 0808 800 5050
- International +44 113 210 8850
- Email: helpline@epilepsy.org.uk
- Twitter: epilepsyadvice
- Txt msg: 0753 741 0044 info







